Adlington, R.M., Baldwin, J.E., Becker, G.W., Chen, B., Cheng, L., and
Cooper, S.L., “Design, synthesis, and proposed active site binding analysis of
monocyclic 2-azetidinone inhibitors of prostate specifics antigen,” J. Med.
Chem., 2001, 44, 1491–1508.
Alan, A.W., “Use of the berthelot reaction in the automated analysis of serum
urea nitrogen”, Clin. Chem., 1966, 12, 151-157.
Aliasghar, J., and Maaroof, Z., “Synthesis of novel n-sulfonyl monocyclic βlactams as potential antibacterial agents,” Molecules, 2006, 11, 49-58.
Alistair, K., Sudharsan, S., Laurent, K., Sandra, L., Lynn, G., James, C. and
Gurdyal, S., “Probing the mechanism of the Mycobacterium tuberculosis βketoacyl-acyl carrier protein synthase III : Factors influencing catalysis and
substrate specificity. J. Biol. Chem., 2005, 280, 32539-32547.
Amit, V., and Shailendra, K.S “4-Thiazolidinone – A biologically active
scaffold,” Eur. J. Med. Chem., 2001, 43, 897-905.
Antonio, C., Paolo, S., Laura, G., Donatella, U. and Stefania, Z., “Novel
functionalized pyrido[2,3-g]quinoxalinones as antibacterial,antifungal and
anticancer agents,” Farmaco, 2001, 56, 933–938.
Asha, B., Abdul, R.B. and Amir, A., “Synthesis of new 2-(5-substituted-3phenyl-2-pyrazolinyl)-1,3-thiazolino[5,4-b]quinoxaline
evaluation of their antiamoebic activity,” Eur. J. Med. Chem., 2009, 44, 13171325.
Asuncion, B., Eleni, P., Dimitra, H., Raquel, V., Esther, V., Beatriz, S., Saioa, A.,
Silvia, P., Ignacio, A. and Antonio, M., “Synthesis and antiinflammatory/
antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-Noxidequinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro(1H)-pyrazole analogues,” Bioorg. Med. Chem. Lett., 2007, 17, 6439–6443.
Aysel, G., Taylan, I., Nalan, T. and Gulten T., “Synthesis and antimicrobial
evaluation of some novel imidazolyl mercapto acetyl thiosemicarbazide and
4-thiazolidinone analogs,” Turkish J. Pharm. Sci., 2005, 2, 1-10.
Balzarini, J., Rao, A., Carbone, A., Chimirri, A., Clercq, E.D., Monforte,
A.M., Monforte, P., Pannecouque, C. and Zappala, M., “Synthesis of new 2,3diaryl-1,3-thiazolidin-4-ones as antiHIV agents,” Farmaco, 2004, 59, 33-39.
Bharti, A.R., Nally, J.E. and Ricaldi, J.N., “Leptospirosis: A zoonotic disease of
global importance,” Lancet Infect. Dis., 2003, 3, 757–771.
Bhoot, D.P., Khunt, R.C., Shankhavara, V.K. and Parekh, H.H., “Synthesis of
some new heterocyclic compounds with potential biological activity,” J. Sci.
I. R. Iran, 2006, 17, 323-325.
Chan, S.C., Wen, X.R. and Sang, C.S., “Ketones as a new synthon for
quinoxaline synthesis,” Tetrahedron Lett., 2007, 48, 4665-4667.
Chatrabhuji, P.M., Vyas, K.B., Nimavat, K.S. and Undavia, N.K., “Synthesis
and antimicrobial activity of some 4 - oxo – thiazolidines-5- acetic acids,”
Asian J. Biochem. Pharm. Res., 2009, 1, 2231-2560.
Chavan, A.A. and Pai, N.R., “Synthesis and biological activity of nsubstituted 3-chloro-2-azetidinones,” Molecules, 2007, 12, 2467-2477.
Colette, G. and Jean-Marie, G., “Biochemistry and comparative genomics of
sxxk superfamily acyltransferases offer a clue to the mycobacterial paradox:
presence of penicillin-susceptible target proteins versus lack of efficiency of
penicillin as therapeutic agent,” Microbiol. Mol. Biol.Rev., 2002, 76, 702-738.
Desai, N.C., Dave, D., Shah, M.D. and Vyas, G.D., “Synthesis and
antibacterial activity of some novel 4-oxo-1,3-thiazolidines, 2-oxoazetidines
and 5-oxoimidazolines,” Indian J. Chem., 2000, 39, 277-282.
Desai, N.C., Shah, M.D. and Bhavsar, A.M., “Synthesis and QSAR studies of
4-oxothiazolidines and 2-oxoazetidines as potential antibacterial agents,”
Indian J. Chem., 2008, 47, 1135-1144.
Dharmchand, P.S., Sanjaykumar, D., Syed, R.H. and Ramgopal. S.,
“Synthesis and antimicrobial activity of some new quinoxaline derivatives,”
Pharmaceuticals, 2010, 3, 2416-2425.
Esther, V., Silvia, P.S., Lidia, M.L., Saioa, A., Asuncion, B., Beatriz, S.,
Raquel, V., Ignacio, A. and Antonio, M., “Selective activity against
Mycobacterium tuberculosis of new quinoxaline1,4-di-N-oxides,” Bioorg.
Med. Chem., 2009, 17, 385–389.
Giri, S., Sharan, P. and Nizamuddin, A., “Syntheses of some 1-(substituted
coumarin-3-carboxamido)-3-substituted-4-aryl-2-azetidinones as potential
antifungal agents,” Agricul. Biol. Chem., 1989, 53, 1153-1155.
Girija, S.S., and Boycie, J.M., “Synthesis of 2-azetidinones from 2-diazo-1, 2diarylethanonesand N-(2-thienylidene)imines as possible antimicrobial
agents,” Farmaco, 2005, 60, 727–730.
Goel, R.K., Singh, A., Naidu, P.S., Mahajan, M.P. and Kulkarni, S.K., “PASS
assisted search and evaluation of some azetidin-2-ones as C.N.S. active
agents,” J. Pharm. Pharmaceut. Sci., 2005, 8, 182- 189.
Grinev, A.N ., “6-Substituted indolo[1,2-c]quinazolines as new antimicrobial
agents”, Pharm Chem J, 1978,12, 233-236.
Halve, A. K., Bhadauria, D., and Dubey, R., “N/C-4 substituted azetidin-2ones, synthesis and preliminary evaluation as antimicrobial agent,” Bioorg.
Med. Chem., 2007, 17, 341-345.
Hasaninejada, A.Z., Mohammadizadeha, M.R. and Karamia, Z., “Synthesis of
quinoxaline derivatives via condensation of aryl-1,2-diamines with1,2diketones using (NH4)6MO7O24. 4H2O as an efficient, mild and reusable
catalyst,” J. Iran. Chem. Soc., 2009, 6, 153-158.
Hongyu, Z., Shuhong, W., Shumei, Z., Aifeng, L., Ying, S., Rongshi, L.,
Ying, Z., Sean, E., Peter, W., Swaan, O., Bingliang, F., Bin, Z., and Bing, Y.,
“Design, synthesis, cytoselective toxicity, structure–activity relationships, and
pharmacophore of thiazolidinone derivatives targeting drug resistant lung
cancer cells,” J. Med. Chem., 2008, 51, 1242–1251.
Itamar, S., Ada, B. and Abraham, S., “Efficacy of ciprofloxacin against
leptospira interrogans serogroup icterohaemorrhagiae,” Antimicrob.
Agents Chemother., 1989, 33, 788-789.
Jasmer, R.M., Nahid, P.and Hopewell, P.C., “Clinical practice: Latent
tuberculosis infection,” N. Engl. J. Med., 2002, 347, 1860–1866.
Jean, R., Michel, B. and Patrick, M., “Quinoxaline-5,6-(and 5-8)-dionespotential antitumoral agents,” Eur. J. Med. Chem., 1981, 16, 545-550.
Johannes, G.V., Gerhard, H., and Gerhard, S., “Facile retro dieckmann
reactions of 3-0xo-carbapenam esters”, Heterocycles, 1985, 23, 1081-1084.
Jonathan, D.G. and Lowell, H.H., “Modeling antileukemic activity of
carboquinones with electrotopological state and chi indices,” J. Chem. Inf.
Comput. Sci., 1999, 39, 356-364.
Julius, A.G., “The calorimetric determination of r-glutamyl transpeptidase
with a synthetic substrate,” Arch. Biochem. Biophys. 1960, 91, 61-70.
Kaythara, P., Upadhayay, T., Doshi. R., and Parel, H.H., “Synthesis of some
2- azetidinones as potential antitubercular agents,” Indian J. Heterocycl.
Chem., 2000, 10, 9-12.
Kiktenko, V.S., Balashov, N.G. and Rodina, V.N., “Leptospirosis infection
through insemination of animals,” J. Hyg. Epidemiol. Microbiol.
Immunol., 1976, 21, 207-213.
King, E.J., “A method for the determination of tartratelabile, prostatic acid
phosphatase in serum,” Am. J. Cli. Path., 1959, 12, 85-89.
Knut, B., “An alignment-independent versatile structure descriptor for qsar
and qspr based on the distribution of molecular features,” J. Chem. Inf.
Comput. Sci., 2002, 42, 26-35.
Konstantinos, A., “Testing for tuberculosis,” Australian Prescriber, 2010, 33,
Kumar, V., Abbas, A.K., Fausto, N. and Mitchell, R.N., “Robins basic
pathology” (8th ed.) Saunders Elseviers, Philadelphia, 2007, pp 516-522.
Kyoung, S.K., Synthesis, biological properties, and structure-activity
relationships of quinoxaline angiotensin II receptor antagonists. Bioorg. Med.
Chem. Let., 1993, 3, 2667-2670.
Kyoung, S.K., Synthesis, biological properties, and structure-activity
relationships of quinoxaline angiotensin II receptor antagonists. Bioorg. Med.
Chem. Let., 1993, 3, 2667-2670.
Langston, C.E. and Heuter, K.J., “Leptospirosis. A re-emerging zoonotic
disease,” Vet. Clin. N.- Am.- Small., 2003, 33, 791–807.
Lowell, H.H. and Lemont, B.K., “Issues in representation of molecular
structure-the development of molecular connectivity,” J. Mol. Graphics
Modell., 2001, 20, 2-14.
Mahendra, R.S., Mangesh, G., Kailash, G.B., Shashikant, V.B., Ana, N.,
Kalyan, C.A., Nisheeth, C.D. and Prashant, J.B., “Synthesis and
anticonvulsant activity of clubbed thiazolidinone–barbituric acid and
thiazolidinone–triazole derivatives,” Arkivoc, 2007, (xiv), 58-74.
Majid, M.H., Khadijeh, B., Maryam, H.T., Negar, M.J. and Hossien, A.O.,
“Facile synthesis of quinoxaline derivatives using o-iodoxybenzoic acid
(IBX) at room temperature,” Arkivoc, 2006, (xvi), 1424-6376.
Majid, M.H., Shima, T., Khadijeh, B. and Hossein, A.O., “On water: A
practical and efficient synthesis of quinoxaline derivatives catalyzed by
CuSO4 · 5H2O,” Catal. Commun., 2007, 8, 211-214.
Malawska, B., “New anticonvulsant agents,” Current Top. Med. Chem., 2005,
5, 69-85.
Marisithambaram, K., Dasappa, J.P., Bojapoojary, K., Subrahmanya, B.,
Bantwal, S.H. and Nalilu, S.K., “Synthesis and biological activity of Schiff
and Mannich bases bearing 2,4-dichloro-5-fluorophenyl moiety” Bioorg.
Med. Chem., 2006, 14, 7482-7489.
Michael, P. and Malcolm, M., “Measurement of serum creatinine – current
status and future goals,” Clin. Biochem. Rev., 2006, 27, 173-184.
Nagraja, G.K., Marlingaplara, G.P., and Mahadevan, K., “Synthesis of novel
nitrogen containing naphtha-[2,1-b]-furan derivatives and investigations of
their antimicrobial activities”, Arkovick, 2006, (xv), 664-674.
Naoyuki, Y., “Influence of nonspecific reaction on determination of H2O2
using trinder reagents”, Clinica Chimica Acta, 2005, 360, 52-59.
Navin, B.P. and Sarvil, D. P., “Synthesis and in vitro antimicrobial study of
schiff base and thiazolidinone of 1-cyclopropyl-6-fluoro-7-[4-(2,3dichlorophenyl) piperazin-1-yl]-4-quinolone,” Acta Pol. Pharm. Drug Res.,
2010, 67, 45-53.
Paola, V., Athina, G., Kitka, A., Matteo, I. and Franca, Z., “Synthesis and
2-thiazolylimino-5-arylidene-4thiazolidinones,” Bioorg. Med. Chem., 2006, 14, 3859-3864.
Paolo, S., Antonio, C., Mario, L., Stefania, Z. and Leonardo, S., “Synthesis of
substituted 2-ethoxycarbonyl- and 2-carboxyquinoxalin-3-ones for evaluation
of antimicrobial and anticancer activity,” Farmaco, 1998, 53, 455-461.
Parekh, H.H., Parikh, K.A. and. Parikh, A.R., “Synthesis of some 4thiazolidinone derivatives as antitubercular agents,” J. Sci. I. Rep. Iran, 2004,
15, 143-148.
Parikh, K.A., Oza, P.S., Bhatt, S.B., and Parikh, A.R., “Synthesis of some
new 2-azetidinones as potential antitubercular agents,” Indian J. Chem.,
2000, 39, 716-718.
Pierre, A., Hans, A., Yves, P.A., Serge, B., Silvio, O., Dirk, S. and Markus, S.,
“5-Aminomethylquinoxaline-2,3-diones: Arylamide derivatives as highly
potent and selective glycine-site NMDA receptor antagonists,” Bioorg. Med.
Chem. Lett., 1998, 8, 493-498
Predvoditeleva, G.S., Kartseva, T.V., Oleshko, O.N., Shvedov, V.I. and
Pershin, G.N., “Synthesis and study of the tuberculostatic activity of alkyl
derivatives of dihydropyridazino[3,4-b]quinoxalines,” J. Pharm. Chem.,
1977, 11, 1349-1353.
Rajesh, H.B., Mukul, R.J., Arun, A.G., Ashish, G., Pradip, A.J., Dipam, N.P.,
Vijay, M.P. and Pankaj, R.P., “Synthesis and antidiabetic activity of 3,6,7trisubstituted-2-(1h-imidazol-2-ylsulfanyl)quinoxalines and quinoxalin-2-yl
isothioureas,” Archiv der Pharmazie, 2007, 340, 359–366.
Rao, A., Balzarini, J., Carbone, A., Chimirri, A., Clercq, E.D., Monforte, A.
M., Monforte, P., Pannecouque, C. and Zappalà, M., “Discovery of 2,3diaryl-1,3-thiazolidin-4-ones as potent antiHIV-1 agent,” Bioorg. Med.
Chem. Lett., 2001, 11, 1793–1796.
Rao, A., Carbone, A., Chimirri, A., Clercq, E.D., Monforte, A.M., Pietro, M.,
Pannecouque, C. and Zappala, M., “Synthesis and antiHIV activity of 2,3diaryl-1,3-thiazolidin- 4-(thi)one derivatives,” Farmaco, 2002, 57, 747-751.
Ravichandran, V., Mohan, S. and Suresh Kumar, K., “Synthesis and
antimicrobial activity of Mannich bases of isatin and its derivatives with 2[(2,6-dichlorophenyl)amino]phenylacetic acid,” Arkivoc, 2007, (xiv), 51-57.
Sandip, J., Mahesh, P., Veeresh, M., Pradeepkumar, R., Shivalingarao M.,
Darbhamulla, S., and Mangala, G., “Synthesis and antimycobacterial activity
of a novel series of isonicotinylhydrazide derivatives,” Arch. Pharm. Chem.
Life Sci., 2009, 342, 723–731.
Saraswathi, M., Rohini, R.M., Singh, V. and Naira, N., “Synthesis and
evaluation of Mannich bases of benzimidazo [1,2-c] quinazolin- 6(5h)thionefor antimicrobial activity,” Pak. J. Pharm. Sci., 2010, 23, 459-462.
Saravanan, R., Rajendran, P. and Garajan, S.P., Clinical, bacteriologic and
histopathologic studies on induced leptospirosis in stray dog pups. Indian J.
Patho. Microbiol., 1999, 42, 463-469.
Sathe, B.S., Jaychandran, E., Jagtap, V. A. and Sreenivasa, G.M., “Antitubercular activity of fluoro benzothiazole comprising potent thaizolidinone,”
Int. J. Pharma. Bio Sci., 2010, 1, 332-337.
Seshaiah, K.S., Muniyandy, S. and Atmakuru R., “Synthesis and antibacterial
screening of hydrazones, Schiff and Mannich bases of isatin derivatives,”
Sharma, M.C., Sahu, N.K., Kohli, D.V., Chaturvedi, S.C., Smita, S.,
“Synthesis, characterization and biological activities of some 1(nicotinylamino) -2 substituted azetidine-4 -ones as potential antibacterial
agents,” Dig. J. Nanomat. Bios., 2009, 4, 361 – 367.
Sheela, J., Navita, K., Deepak, K. and Rakesh, S., “Synthesis and in vitro
study of novel Mannich bases as antibacterial agents,” Bioorg. Med. Chem.
Lett., 2005, 15, 221-226.
Shu-Kun, L., “A facile synthesis of quinoxaline–2,3–diones as NMDA
receptor antagonists,” Molecules, 1996, 1, 37-40.
Smythe, L., “Leptospirosis – A review of laboratory diagnostic methods”,
Aust. J. Med. Sci., 2006, 27, 16-19.
Sriram, D., Bal, T.R. and Yogeeswari, P., Newer aminopyrimidinimino isatin
analogues as non-nucleoside HIV-1 reverse transcriptase inhibitors for HIV
and other opportunistic infections of AIDS: Design, synthesis and biological
evaluation ,” Farmaco, 2005, 60, 377–384,
Srivastava, S.K., Srivatsava, S., and Srivastava, S.D., “Synthesis of new
carbazolylthiadiazol-2-oxoazetidines,” Indian J. Chem., 1999, 36, 183-187.
Subudhi, B.B., Panda, P.K., Tosh, B.K., Sahu, S., and Majhi, P., “synthesis
and biological activity evaluation of some azetidinone and thiazolidinone
derivatives of coumarins,” Dhaka Univ. J. Pharm. Sci., 2005, 4, 87-92.
Tom, D., “Early historical milestones in HDL-cholesterol assay,” Clin.
Chem., 1998, 44, 898-899.
Vazzana, I., Terranova, E., Mattioli, F., and Sparatore, F., “Aromatic schiff
bases and 2,3-disubstituted-1,3-thiazolidin-4-one derivatives as antiinflammatory agents,” Arkivoc, 2004, (v), 364-374.
Vishnu, K.T., Dharmendra, B.Y., Hardesh, K.M., Ashok, K.C. and Praveen,
K.S., “Design, synthesis, and biological evaluation of 1,2,3-trisubstituted-1,4dihydrobenzo [g]quinoxaline-5,10-diones and related compounds as antifungal
and antibacterial agents,” Bioorg. Med. Chem., 2006, 14, 6120–6126.
Viswajanani, J.S., Ajay, S., Smita, S., Seema, K., Manisha, P., Pragya, B.,
Tarun, M., Ashok, R., JagMohan, K. and Anita, M., “Synthesis and
antimicrobial activity of novel thiazolidinones,” Arkivoc, 2005, (ii), 46-59.
Xu, H., Julie, D., Christian, B., Philippe, M.L., Xavier, F.,Reynald, H. and
Bruno, F., “Synthesis and antiprotozoal activity of some new synthetic
substituted quinoxalines,” Bioorg. Med. Chem. Lett., 2006, 16, 815–820.
Yanofsky, S.D., Shen, E.S., Holden, F., Whitehorn, E., Aguilar, B., Tate, E.,
Holmes, C.P., Scheuerman, R., MacLean, D., Wu, M.M., Frail, D.E., López,
F.J., Winneker, R., Arey, B.J., and Barrett, R.W., “Allosteric activation of the
follicle-stimulating hormone (FSH) receptor by selective nonpeptide
agonists,” J. Biol. Chem., 2006, 281, 13226-13237.
Yun, B.K., “Synthesis and biological activity of new quinoxaline antibiotics
of echinomycin analogues,” Bioorg. Med. Chem. Let., 2004, 14, 541-544.